PKC inhibitors RO 31-8220 and Gö 6983 enhance epinephrine-induced platelet aggregation in catecholamine hypo-responsive platelets by enhancing Akt phosphorylation

BMB Reports

Volumn 44, Issue 2, 2011, Pages 140-145

  Kim, Sun Young ^a   Kim, Sewoon ^b   Kim, Jeong Mi ^a   Jho, Eek hoon ^b   Park, Seonyang ^a   Oh, Doyeun ^c   Yun Choi, Hye Sook ^a  

^a Seoul National University   (South Korea)

^b University of Seoul   (South Korea)

^c CHA University   (South Korea)

Author keywords

Akt; Epinephrine; G 6983; Platelet aggregation; RO 31 8220

Indexed keywords

EID: 79952057097     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2011.44.2.140     Document Type: Article

References (29)

1. Siess, W. (1989) Molecular mechanisms of platelet activation. Physiol. Rev. 69, 58-178.
2. Packham, M. A. (1994) Role of platelets in thrombosis and hemostasis. Can. J. Physiol. Pharmacol. 72, 278-284.
3. Assoian, R. K., Komoriya, A., Meyers, C. A., Miller, D. M. and Sporn, M. B. (1983) Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J. Biol. Chem. 258, 7155-7160.
4. Holmsen, H. (1991) Signal transducing mechanisms in platelets. Proc. Natl. Sci. Counc. Repub. China B. 15, 147-152.
5. Chen, J., De, S., Damron, D. S., Chen, W. S., Hay, N. and Byzova, T. (2004) Imparied platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood 104, 1703-1710.
6. Kambayashi, J., Shinoki, N., Nakamura, T., Ariyoshi, H., Kawasaki, T., Sakon, M. and Monden, M. (1996) Prevalence of impaired responsiveness to epinephrine in platelets among Japanese. Throm. Res. 81, 85-90.
7. Pyo, M. K., Yun-Choi, H. S. and Hong, Y. J. (2003) Apparent heterogeneous responsiveness of human platelet rich plasma to catecholamines. Platelets. 14, 171-178.
8. Kim, J. M., Koo, Y. K., Heo, J. E., Park, S. and Yun-Choi, H. S. (2009) Reduced GPIIb/IIIa expression in platelets hyposensitive to catecholamines when activated with TRAP. Throm. Res. 124, 90-95.
9. Nakahashi, T. K., Kambayashi, J., Nakamura, T., Le, S. N., Yoshitake, M., Tandon, N. N. and Sun, B. (2001) Platelets in nonresponders to epinephrine stimulation showed reduced response to ADP. Throm. Res. 104, 127-135.
10. Koo, Y. K., Kim, J. M., Kim, S. Y., Koo, J. Y., Oh, D., Park, S. and Yun-choi, H. S. (2009) Elevated plasma concentration of NO and cGMP may be responsible for the decreased platelet aggregation and platelet leukocyte conjugation in platelets hypo-responsive to catecholamines. Platelets. 20, 555-565.
11. 2A-receptor. J. Biol. Chem. 274, 29108-29114.
12. 2A-Aderenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels. J. Biol. Chem. 275, 1763-1772.
13. Anfossi, G. and Trovati, M. (1996) Role of catecholamines in platelet function: pathophysiological and clinical significance. Eur. J. Clin. Invest. 26, 353-370.
14. 12 receptor in platelet activation. J. Clin. Invest. 113, 340-345.
15. Shah, B. H. and Saeed, S. A. (1995) Phosphatidylinositol 3-kinase inhibitor, wortmannin, inhibits 5-hydroxytrypt-amine-mediated potentiation of platelet aggregation induced by epinephrine. Res. Commun. Mol. Pathol. Pharmacol. 89, 157-164.
16. 2 from prostaglandin endoperoxides. Nature 261, 558-560.
17. 2-adrenoceptors in human platelets. J. Cardiovasc. Pharmacol. 40, 743-750.
18. Shah, B. H., Shamim, G., Khan, S. and Saeed, S. A. (1996) Protein kinase C inhibitor, chelerythrine, potentiates the adrenaline-mediated aggregation of human platelets through calcium influx. Biochem. Mol. Biol. Int. 38, 1135-1141.
19. Soltoff, S. P. (2007) Rottlerin: an inappropriate and ineffective inhibitor of PKC δ. Trends Pharmacol. Sci. 28, 453-458.
20. London, F. S. (2003) The protein kinase C inhibitor RO 318220 potentiates thrombin-stimulated platelet-supported prothrombinase activity. Blood 102, 2472-2481.
21. Strehl, A., Munnix, I. C., Kuijpers, M. J., van der Meijden, P. E., Cosemans, J. M., Feijqe, M. A., Nieswandt, B. and Heemskerk, J. W. (2007) Dual role of platelet protein kinase C in thrombus formation: stimulation of pro-aggregatory and suppression of procoagulant activity in platelets. J. Biol. Chem. 282, 7046-7055.
22. Dorsam, R. T., Kim, S., Murugappan, S., Rachoor, S., Shanker, H., Jin, J. and Kunapuli, S. P. (2005) Differential requirements for calcium and Src family kinases in platelet GPIIb/IIIa activation and thromboxane generation downstream of different G-protein pathways. Blood 105, 2749-2756.
23. (12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin-a phosphoinositide 3-kinase-dependent mechanism. FEBS Lett. 505, 281-290.
24. Yin, H., Stojanovic, A., Hay, N. and Du, X. (2008) The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation. Blood 111, 658-665.
25. Jang, E. K., Azzam, J. E., Dickinson, N. T., Davidson, M. M. and Haslam, R. J. (2002) Roles for both cyclic GMP and cyclic AMP in the inhibition of collagen-induced late-let aggregation by nitroprusside. Br. J. Haemotol. 117, 664-675.
26. Swart, S. S., Maguire, M., Wood, J. K. and Barnett, D. B. (1985) Alpha 2-adrenoceptor coupling to adenylate cyclase in adrenaline insensitive human platelet. Eur. J. Pharmacol. 116, 113-119.
27. Nakamura, T., Ariyoshi, H., Kambayashi, J., Ikeda, M., Shinoki, N., Kawasaki, T. and Monden, M. (1997) Signal transduction system in epinephrine stimulated platelets; comparison between epinephrine sensitive and insensitive platelets. Throm. Res. 85, 83-93.
28. i signaling pathways. J. Biol. Chem. 279, 4186-4195.
29. McNicol A. (1996) Platelet preparation and estimation of functional response; in Platelets-A Practical Approach. (Watson, S. P. and Authi, K. S., eds.), pp 1-13, Press at Oxford University Press, New York, U.S.A.